-
Mashup Score: 3Patient’s white blood cells genetically changed into cancer killers - Hamilton Health Sciences - 2 year(s) ago
A new medication available at Hamilton Health Sciences for CAR T-cell therapy brings hope to some end-of-life patients.
Source: Hamilton Health SciencesCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Reflections on a rich and remarkable life - Macleans.ca - 3 year(s) ago
In 2019, an MDS diagnosis stopped Bob Markovich in his tracks. With his condition now under control, he’s able to look back on a life well-lived while remaining focused on the future
Source: Macleans.caCategories: Hem/Oncs, Latest HeadlinesTweet-
@Dr_AmerZeidan https://t.co/1r5uca80W0 nothing can be as rewarding as patients’ gratitude
-
-
Mashup Score: 0Macleans.ca - Canada's magazine since 1905 - 3 year(s) ago
Canada’s magazine since 1905
Source: Macleans.caCategories: Hem/Oncs, Latest HeadlinesTweet-
It is humbling to be involved in Bob’s care and be part of his brave journey! Reflections on a rich and remarkable life - https://t.co/HewnpaFFoF https://t.co/1r5uc9Qq4s
-
-
Mashup Score: 0A natural history of lower-risk myelodysplastic syndromes with ring sideroblasts: an analysis of the MDS-CAN registry - 3 year(s) ago
Patients with lower-risk (LR) myelodysplastic syndromes (MDS) with ring sideroblasts (RS) have better prognosis than those without RS, but how they fare over time is not fully understood. This stud…
Source: Taylor & FrancisCategories: Hem/Oncs, Latest HeadlinesTweet-
Proud of our #Nature published paper on outcomes of low risk MDS #MDSCan #MDSsm #Leuksm we got the Queen of MDS @renabuckstein https://t.co/D2enPcwgSk
-
-
Mashup Score: 0Cell Architecture Drives MDS and Progression, Could Guide Second-Line Treatment | ASH Clinical News | American Society of Hematology - 3 year(s) ago
Skip Nav Destination June 27, 2022 The hematopoietic cell architecture in myelodysplastic syndromes (MDS) may have the potential to predict disease progression and guide use of second-line treatment after hypomethylating agent (HMA)-based…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Cell Architecture Drives MDS and Progression, Could Guide Second-Line Treatment | ASH Clinical News | American Society of Hematology https://t.co/DJeID4CWFy
-
-
Mashup Score: 1Which Immune Cell Are You? - 3 year(s) ago
Take this personality quiz to find out which immune cell you’re most like.
Source: www.stemcell.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Thanks @Dr_AmerZeidan whosayshemecantbefun #IamaMonocyte What Type of Immune Cell are You? https://t.co/h1KpMegPyb
-
-
Mashup Score: 0ASH 2021 - 4 year(s) ago
Download the program for ASH21. Easily access event sessions, speakers, exhibitors, and organizer messages. Download the native app to personalize your schedule (synchronized to virtual platform), take notes, share contacts, and more. Try the interactive web…
Source: eventpilot.usCategories: Hem/Oncs, Latest HeadlinesTweet-
Our Poster @ASH21 #Fitness Assessment of Elderly Patients with AML and Outcomes https://t.co/Ka8GztwNHZ #ASH21 #Leuksm #frailty #AML
-
Patient’s white blood cells genetically changed into cancer killers - Hamilton Health Sciences #cellulartherapy #immunotherapy #CarT #hemesm @HHS_Health @HHS_staff @HHS_Innovates #JuravinskiCancerCentre https://t.co/9g5oNo658c